123 related articles for article (PubMed ID: 24481389)
1. Relief from cancer chemotherapy side effects with pharmacologic vitamin C.
Carr AC; Vissers MC; Cook J
N Z Med J; 2014 Jan; 127(1388):66-70. PubMed ID: 24481389
[TBL] [Abstract][Full Text] [Related]
2. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
Schmaltz J
Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
[No Abstract] [Full Text] [Related]
3. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
Fulop JA
Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
[No Abstract] [Full Text] [Related]
4. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients.
Biswal BM; Sulaiman SA; Ismail HC; Zakaria H; Musa KI
Integr Cancer Ther; 2013 Jul; 12(4):312-22. PubMed ID: 23142798
[TBL] [Abstract][Full Text] [Related]
5. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
Boyd DB
Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
[No Abstract] [Full Text] [Related]
6. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
7. [Tumor recurrence in the salvaged breast; a second chance?].
Roukema JA; Dolman A; Maat B
Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2593-5. PubMed ID: 2558321
[No Abstract] [Full Text] [Related]
8. [Prevalence and course of fatigue in breast cancer: the kind of chemotherapy plays a role].
de Jong N; Candel M; Schouten H; Abu-Saad HH; Courtens A
Pflege Z; 2005 Feb; 58(2):100-3. PubMed ID: 15754508
[No Abstract] [Full Text] [Related]
9. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.
Suhail N; Bilal N; Khan HY; Hasan S; Sharma S; Khan F; Mansoor T; Banu N
J Clin Pharm Ther; 2012 Feb; 37(1):22-6. PubMed ID: 21204889
[TBL] [Abstract][Full Text] [Related]
10. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer.
Mills PJ; Parker B; Dimsdale JE; Sadler GR; Ancoli-Israel S
Biol Psychol; 2005 Apr; 69(1):85-96. PubMed ID: 15740827
[TBL] [Abstract][Full Text] [Related]
11. AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
Gianni L; Romieu GH; Lichinitser M; Serrano SV; Mansutti M; Pivot X; Mariani P; Andre F; Chan A; Lipatov O; Chan S; Wardley A; Greil R; Moore N; Prot S; Pallaud C; Semiglazov V
J Clin Oncol; 2013 May; 31(14):1719-25. PubMed ID: 23569311
[TBL] [Abstract][Full Text] [Related]
12. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
14. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany.
Vollbracht C; Schneider B; Leendert V; Weiss G; Auerbach L; Beuth J
In Vivo; 2011; 25(6):983-90. PubMed ID: 22021693
[TBL] [Abstract][Full Text] [Related]
15. Weekly topotecan and daily thalidomide in patients with recurrent epithelial ovarian cancer: a report of 2 cases.
Phippen NT; Leath CA
J Reprod Med; 2009 Sep; 54(9):583-6. PubMed ID: 19947038
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients].
Saeki T; Jinushi K; Kim R; Toi M; Saeki K; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):827-31. PubMed ID: 2712579
[TBL] [Abstract][Full Text] [Related]
17. Follow-up care of patients with breast cancer.
Tolaney SM; Winer EP
Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
19. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
